Developer docs
API playgroundTry for free, no card

Search company profiles

NephroPlus

Full company profile

uuid0000d1z

Namestring
NephroPlus
Legal namestring
Nephrocare Health Services Limited
Websiteurl
nephroplus.com
Company typeenum
Public
Founded yearint
2009
Descriptiontext

NephroPlus operates Asia's largest dialysis care network, with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia serving over 33,000 patients annually. Founded in 2009 and headquartered in Hyderabad, the company delivered 3.84 million dialysis treatments in FY26 across service modalities including In-Clinic Dialysis, Dialysis on Call (hospital bedside), Home Hemodialysis, Holiday Dialysis (cross-border travel), and Dialysis on Wheels (mobile units). The clinical operation is underpinned by proprietary technology such as the Renova automated dialyzer reprocessing system and an AI-enabled remote monitoring platform that tracks 28 clinical parameters per session, deployed initially within the Karnataka public-private partnership program.

The revenue model is anchored in per-treatment fees from a mix of individual patients, government PPP contracts (notably the Karnataka state program), and corporate insurance / TPA channels. International operations contributed 42% of FY26 revenue, reflecting a deliberate multi-country expansion funded in part by a Rs 69.5 crore Asian Development Bank loan for the Uzbekistan buildout and a series of Philippines acquisitions. NephroPlus holds NABH and ISO 27001 accreditations and runs the NephroPlus Academy, which has trained over 1,000 clinical staff over nine years.

The company completed an IPO in December 2025, raising Rs 871 crore earmarked for 167 new clinics and pre-payment of debt. Pre-IPO investors Quadria Capital (~30% retained) and Bessemer Venture Partners have backed both organic growth and inorganic expansion through Renal Therapy Solutions Inc. (Feb 2024), seven additional Philippines clinics (Feb 2025), and Amica Healthcare System dialysis assets (June 2026). FY26 revenue of Rs 998.8 crore grew 32.2% year-over-year with adjusted consolidated net profit up 74.6%, and management has guided to 15-20% revenue CAGR over the next 3-4 years.

Short descriptiontext

NephroPlus operates Asia's largest dialysis care network with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia, serving 33,000+ patients annually via in-clinic, home, holiday, and mobile dialysis modalities backed by proprietary clinical technology.

Operating statusenum
Ipo
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dialysis services, kidney care, hemodialysis treatment, nephrology services, dialysis network
Industry5 codes
PRIMARYHLAKAHAC
Dialysis Services (Hemodialysis & Peritoneal Dialysis)
SECONDARYHLAKAHAK
Home Dialysis Programs (Home HD/PD Training & Support)
SECONDARYHLAFABAE
Outpatient Dialysis & Kidney Care Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLALAFAC
Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAFAEAG
Home Dialysis Support & Training Providers
NAICS code3 codes
  • Kidney Dialysis Centers621492
  • Ambulatory Health Care Services621
  • Home Health Equipment Rental532283
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Home Health Care Services8082
Product category
Dialysis Care Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Dialysis Treatment Services
TypeSubscription Recurring
Description

Revenue from providing dialysis treatments to patients across 520+ centers in India and internationally. Revenue grew 32.2% to Rs 998.8 crore in FY26 with 38.4 lakh treatments performed.

business-standard.com
2Public-Private Partnership (PPP) Programs
TypeManaged Services
Description

Government partnerships such as the Karnataka PPP dialysis programme where the company provides dialysis services in government hospitals.

business-standard.com
3Home and Specialty Dialysis Services
TypeManaged Services
Description

Premium services including Home Hemodialysis, Dialysis on Wheels, Dialysis on Call, and Holiday Dialysis programs for travelers.

nephroplus.com
4Training and Academy Services
TypeProfessional Services
Description

NephroPlus Academy provides dialysis technician and nursing training with placement services.

nephroplus.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details4 tiers
1In-Clinic Dialysis - Standard dialysis treatment at NephroPlus centers
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed; operates with insurance providers for cashless treatment; transparent billing with no hidden costs

nephroplus.com
2Home Hemodialysis - Dialysis treatment at patient's home
ModelOtherBilling cadenceMonthly
Notes

Equipment setup, regular monitoring, and maintenance included; pricing varies based on treatment frequency

nephroplus.com
3Holiday Dialysis - Dialysis services at tourist destinations
ModelOtherBilling cadencePay-as-you-go
Notes

Arranged for traveling patients at NephroPlus centers across popular holiday destinations

nephroplus.com
4Dialysis on Wheels - Mobile dialysis van service
ModelOtherBilling cadencePay-as-you-go
Notes

Dialysis treatment delivered to patient's doorstep or workplace location

nephroplus.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1Dialysis on Wheels
Description

Mobile dialysis van service for patients needing on-site care

nephroplus.com
+5 more records
Core offering1 text field

NephroPlus operates a multi-modal dialysis care network providing in-clinic dialysis at 520+ centers across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia. The company also delivers dialysis treatment through home-based setups, mobile vans (Dialysis on Wheels), temporary setups delivered to patient locations (Dialysis on Call), and a holiday dialysis program for traveling patients. It supplements these with digital services including a mobile app, AI-enabled clinical monitoring, and a technician training academy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 32% year-on-year revenue growth to ₹998.8 crore in FY26
+4 more records
Product overview1 text field

NephroPlus operates a multi-modal dialysis care platform providing five distinct service delivery models: In-Clinic Dialysis at their network of 500+ state-of-the-art centres, Dialysis on Call (temporary mobile setup delivered to homes/hospitals), Home Hemodialysis (permanent home installation with equipment and staff), Holiday Dialysis (travel-compatible treatment), and Dialysis on Wheels (mobile van service). The company complements its core dialysis services with a digital ecosystem comprising a mobile app for appointment management, an AI-enabled monitoring system for clinical quality assurance, a Kidney Health Assessment tool, and diet/nutrition support. NephroPlus also operates a Dialysis Academy for technician training and runs patient engagement programmes including the Dialysis Olympiad and Aashayein events.

Product and service7 records
1In-Clinic Dialysis
CategoryCore Dialysis Service
Description

Standard hemodialysis treatment delivered at NephroPlus's 500+ state-of-the-art centers across India, equipped with modern machines, strict hygiene protocols, qualified technicians, in-house entertainment, and patient comfort amenities. Targeted at chronic kidney disease patients requiring regular dialysis.

2Home Hemodialysis
CategoryHome Dialysis Service
Description

Permanent home-based dialysis setup including a hemodialysis machine, water treatment plant, and regular clinical staff monitoring, enabling patients to undergo treatment in the comfort of their homes with reduced infection risk and scheduling flexibility.

3Dialysis on Wheels
CategoryMobile Dialysis Service
Description

Mobile dialysis van service delivering full in-clinic quality dialysis treatment to patients' doorsteps or workplaces, featuring a fully operational ambulance setup with dialysis machine, RO plant, recliner or bed, and trained staff.

4Dialysis on Call
CategoryMobile Dialysis Service
Description

Mobile dialysis service that delivers a complete dialysis setup to the patient's home or hospital location, conducts the procedure, and then removes the equipment, providing temporary dialysis capability without permanent installation.

5Holiday Dialysis
CategoryTravel Dialysis Service
Description

Dialysis service enabling patients to travel while continuing treatment, with NephroPlus managing travel, accommodation, and treatment logistics at destination clinics across India and internationally.

6NephroPlus Mobile App
CategoryDigital Patient Platform
Description

Mobile application for easier appointment bookings, accessing dialysis-related reads, and managing dialysis needs. Available on iOS and Android platforms.

7NephroPlus Dialysis Academy
CategoryEducation and Training Service
Description

Training institute for dialysis technician and nursing professionals that has trained and placed over 1,000 students across NephroPlus centres and leading healthcare institutions over 9 years.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierStrategicTypeTechnology or Integration
Description

Asset Transfer Agreement signed on June 9, 2026 for acquisition of dialysis center assets in Paranaque City, Philippines valued at PhP 32,640,000 (approximately $560,000).

2Karnataka Government
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Public-Private Partnership dialysis programme with Karnataka government where NephroPlus provides AI-enabled monitoring for government dialysis units at KC General Hospital Bengaluru and six other centers.

thehindu.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global dialysis services leader with ~3,100 outpatient clinics in the US and international presence including India. Comparable as the dominant global pure-play dialysis network, with significantly larger scale, established PPP/insurance relationships, and proven multi-modality delivery.

TypeBroad incumbent
Description

World's largest dialysis services and products company, operating ~4,000 clinics globally including India (Fresenius Medical Care India). Comparable on integrated dialysis services plus equipment/dialyzer manufacturing, and a direct competitor for Indian PPP tenders.

TypeDirect peer
Description

Sweden-based pure-play dialysis network with 450+ clinics across 24 countries, including a strong emerging-market focus (Latin America, Middle East, Asia). Highly comparable as a multi-country dialysis services operator pursuing similar international expansion playbook.

4B. Braun Avitum
TypeBroad incumbent
Description

Division of B. Braun Melsungen providing dialysis services (clinics) and hemodialysis products across Europe, Asia, and Africa. Comparable as an integrated dialysis services and equipment provider with international clinic footprint.

TypeBroad incumbent
Description

India's largest hospital chain with extensive nephrology and dialysis programs across 70+ facilities. Comparable as the primary Indian multi-specialty competitor with embedded nephrologist referral pipeline and PPP relationships.

6Fortis Healthcare
TypeBroad incumbent
Description

Major Indian multi-specialty hospital operator with nephrology and dialysis services across its network. Comparable as a domestic competitor using hospital infrastructure to deliver dialysis and capture CKD patient flow.

TypeBroad incumbent
Description

Leading North India hospital chain with nephrology and dialysis programs. Comparable as an Indian listed multi-specialty competitor that NephroPlus competes with for nephrologist affiliations and PPP contracts.

TypeDirect peer
Description

US-based dialysis services company operating ~400 in-center and home dialysis clinics. Comparable as a PE-backed (Bain Capital, KKR) multi-state pure-play dialysis services operator with home dialysis emphasis.

TypeDirect peer
Description

US non-profit dialysis provider operating 250+ clinics across 30 states. Comparable as a long-established multi-state pure-play dialysis services network, though non-profit status differentiates funding model.

TypeRegional player
Description

Sri Lanka's largest private hospital chain with nephrology and dialysis services. Comparable as a South Asian regional hospital operator that competes for cross-border medical tourism and validates the regional specialty care thesis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NephroPlus

Dialysis Care Servicesnephroplus.com

NephroPlus operates Asia's largest dialysis care network with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia, serving 33,000+ patients annually via in-clinic, home, holiday, and mobile dialysis modalities backed by proprietary clinical technology.

What NephroPlus does

NephroPlus operates Asia's largest dialysis care network, with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia serving over 33,000 patients annually. Founded in 2009 and headquartered in Hyderabad, the company delivered 3.84 million dialysis treatments in FY26 across service modalities including In-Clinic Dialysis, Dialysis on Call (hospital bedside), Home Hemodialysis, Holiday Dialysis (cross-border travel), and Dialysis on Wheels (mobile units). The clinical operation is underpinned by proprietary technology such as the Renova automated dialyzer reprocessing system and an AI-enabled remote monitoring platform that tracks 28 clinical parameters per session, deployed initially within the Karnataka public-private partnership program.

The revenue model is anchored in per-treatment fees from a mix of individual patients, government PPP contracts (notably the Karnataka state program), and corporate insurance / TPA channels. International operations contributed 42% of FY26 revenue, reflecting a deliberate multi-country expansion funded in part by a Rs 69.5 crore Asian Development Bank loan for the Uzbekistan buildout and a series of Philippines acquisitions. NephroPlus holds NABH and ISO 27001 accreditations and runs the NephroPlus Academy, which has trained over 1,000 clinical staff over nine years.

The company completed an IPO in December 2025, raising Rs 871 crore earmarked for 167 new clinics and pre-payment of debt. Pre-IPO investors Quadria Capital (~30% retained) and Bessemer Venture Partners have backed both organic growth and inorganic expansion through Renal Therapy Solutions Inc. (Feb 2024), seven additional Philippines clinics (Feb 2025), and Amica Healthcare System dialysis assets (June 2026). FY26 revenue of Rs 998.8 crore grew 32.2% year-over-year with adjusted consolidated net profit up 74.6%, and management has guided to 15-20% revenue CAGR over the next 3-4 years.

NephroPlus firmographics

Firmographics
Name
NephroPlus
Legal name
Nephrocare Health Services Limited
Website
https://nephroplus.com
Company type
Public
Founded year
2009
Operating status
Ipo
Headcount range
1,001–5,000 employees
Short description
NephroPlus operates Asia's largest dialysis care network with 520+ centers across India, Nepal, the Philippines, Uzbekistan, and Saudi Arabia, serving 33,000+ patients annually via in-clinic, home, holiday, and mobile dialysis modalities backed by proprietary clinical technology.
Ownership category
akta.pro rank

NephroPlus industry classification

Industry
Product category
Dialysis Care Services
NAICS
Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Home Health Equipment Rental (532283)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
akta.pro industry
PRIMARYHLAKAHAC
Dialysis Services (Hemodialysis & Peritoneal Dialysis)
SECONDARYHLAKAHAK
Home Dialysis Programs (Home HD/PD Training & Support)
SECONDARYHLAFABAE
Outpatient Dialysis & Kidney Care Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLALAFAC
Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAFAEAG
Home Dialysis Support & Training Providers

Keywords

  • Dialysis services
  • Kidney care
  • Hemodialysis treatment
  • Nephrology services
  • Dialysis network

Where NephroPlus is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices4 records

Markets served

NephroPlus business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Dialysis Treatment Services: Revenue from providing dialysis treatments to patients across 520+ centers in India and internationally. Revenue grew 32.2% to Rs 998.8 crore in FY26 with 38.4 lakh treatments performed.
  2. Public-Private Partnership (PPP) Programs: Government partnerships such as the Karnataka PPP dialysis programme where the company provides dialysis services in government hospitals.
  3. Home and Specialty Dialysis Services: Premium services including Home Hemodialysis, Dialysis on Wheels, Dialysis on Call, and Holiday Dialysis programs for travelers.
  4. Training and Academy Services: NephroPlus Academy provides dialysis technician and nursing training with placement services.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goIn-Clinic Dialysis - Standard dialysis treatment at NephroPlus centers
OtherMonthlyHome Hemodialysis - Dialysis treatment at patient's home
OtherPay-as-you-goHoliday Dialysis - Dialysis services at tourist destinations
OtherPay-as-you-goDialysis on Wheels - Mobile dialysis van service

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

NephroPlus product offering

Product offering

Core offering

NephroPlus operates a multi-modal dialysis care network providing in-clinic dialysis at 520+ centers across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia. The company also delivers dialysis treatment through home-based setups, mobile vans (Dialysis on Wheels), temporary setups delivered to patient locations (Dialysis on Call), and a holiday dialysis program for traveling patients. It supplements these with digital services including a mobile app, AI-enabled clinical monitoring, and a technician training academy.

Product overview

NephroPlus operates a multi-modal dialysis care platform providing five distinct service delivery models: In-Clinic Dialysis at their network of 500+ state-of-the-art centres, Dialysis on Call (temporary mobile setup delivered to homes/hospitals), Home Hemodialysis (permanent home installation with equipment and staff), Holiday Dialysis (travel-compatible treatment), and Dialysis on Wheels (mobile van service). The company complements its core dialysis services with a digital ecosystem comprising a mobile app for appointment management, an AI-enabled monitoring system for clinical quality assurance, a Kidney Health Assessment tool, and diet/nutrition support. NephroPlus also operates a Dialysis Academy for technician training and runs patient engagement programmes including the Dialysis Olympiad and Aashayein events.

Differentiator

Problem solved

Functional benefit

Brands

  • Dialysis on Wheels: Mobile dialysis van service for patients needing on-site care
  • Dialysis on Call
  • Home Hemodialysis
  • Holiday Dialysis
  • Renova
  • NephroPlus Academy

Products and services

  • In-Clinic Dialysis Standard hemodialysis treatment delivered at NephroPlus's 500+ state-of-the-art centers across India, equipped with modern machines, strict hygiene protocols, qualified technicians, in-house entertainment, and patient comfort amenities. Targeted at chronic kidney disease patients requiring regular dialysis.
  • Home Hemodialysis Permanent home-based dialysis setup including a hemodialysis machine, water treatment plant, and regular clinical staff monitoring, enabling patients to undergo treatment in the comfort of their homes with reduced infection risk and scheduling flexibility.
  • Dialysis on Wheels Mobile dialysis van service delivering full in-clinic quality dialysis treatment to patients' doorsteps or workplaces, featuring a fully operational ambulance setup with dialysis machine, RO plant, recliner or bed, and trained staff.
  • Dialysis on Call Mobile dialysis service that delivers a complete dialysis setup to the patient's home or hospital location, conducts the procedure, and then removes the equipment, providing temporary dialysis capability without permanent installation.
  • Holiday Dialysis Dialysis service enabling patients to travel while continuing treatment, with NephroPlus managing travel, accommodation, and treatment logistics at destination clinics across India and internationally.
  • NephroPlus Mobile App Mobile application for easier appointment bookings, accessing dialysis-related reads, and managing dialysis needs. Available on iOS and Android platforms.
  • NephroPlus Dialysis Academy Training institute for dialysis technician and nursing professionals that has trained and placed over 1,000 students across NephroPlus centres and leading healthcare institutions over 9 years.

Quantifiable outcome

  • 32% year-on-year revenue growth to ₹998.8 crore in FY26
  • +4 more outcomes

Companies that use NephroPlus

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

NephroPlus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

NephroPlus partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered strategic and flagship.

  • Amica Healthcare System CorporationstrategicTechnology or IntegrationAsset Transfer Agreement signed on June 9, 2026 for acquisition of dialysis center assets in Paranaque City, Philippines valued at PhP 32,640,000 (approximately $560,000).
  • Karnataka GovernmentflagshipStrategic or Co-development PartnerPublic-Private Partnership dialysis programme with Karnataka government where NephroPlus provides AI-enabled monitoring for government dialysis units at KC General Hospital Bengaluru and six other centers.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

NephroPlus competitors and assessment

Company assessment

Broad incumbents

  • DaVita: Global dialysis services leader with ~3,100 outpatient clinics in the US and international presence including India. Comparable as the dominant global pure-play dialysis network, with significantly larger scale, established PPP/insurance relationships, and proven multi-modality delivery.
  • Fresenius Medical Care: World's largest dialysis services and products company, operating ~4,000 clinics globally including India (Fresenius Medical Care India). Comparable on integrated dialysis services plus equipment/dialyzer manufacturing, and a direct competitor for Indian PPP tenders.
  • B. Braun Avitum: Division of B. Braun Melsungen providing dialysis services (clinics) and hemodialysis products across Europe, Asia, and Africa. Comparable as an integrated dialysis services and equipment provider with international clinic footprint.
  • Apollo Hospitals Enterprise: India's largest hospital chain with extensive nephrology and dialysis programs across 70+ facilities. Comparable as the primary Indian multi-specialty competitor with embedded nephrologist referral pipeline and PPP relationships.
  • Fortis Healthcare: Major Indian multi-specialty hospital operator with nephrology and dialysis services across its network. Comparable as a domestic competitor using hospital infrastructure to deliver dialysis and capture CKD patient flow.
  • Max Healthcare Institute: Leading North India hospital chain with nephrology and dialysis programs. Comparable as an Indian listed multi-specialty competitor that NephroPlus competes with for nephrologist affiliations and PPP contracts.

Direct peers

  • Diaverum: Sweden-based pure-play dialysis network with 450+ clinics across 24 countries, including a strong emerging-market focus (Latin America, Middle East, Asia). Highly comparable as a multi-country dialysis services operator pursuing similar international expansion playbook.
  • U.S. Renal Care: US-based dialysis services company operating ~400 in-center and home dialysis clinics. Comparable as a PE-backed (Bain Capital, KKR) multi-state pure-play dialysis services operator with home dialysis emphasis.
  • Dialysis Clinic, Inc. (DCI): US non-profit dialysis provider operating 250+ clinics across 30 states. Comparable as a long-established multi-state pure-play dialysis services network, though non-profit status differentiates funding model.

Regional players

  • Asiri Hospitals Holdings: Sri Lanka's largest private hospital chain with nephrology and dialysis services. Comparable as a South Asian regional hospital operator that competes for cross-border medical tourism and validates the regional specialty care thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

NephroPlus social profiles

Digital presence

NephroPlus compliance and trust

Trust signal

Compliance3 records

NephroPlus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NephroPlus leadership team

Management profile

Number of profiles

Profiles17 records

NephroPlus subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

NephroPlus funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NephroPlus M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NephroPlus

What does NephroPlus do?

NephroPlus operates a multi-modal dialysis care network providing in-clinic dialysis at 520+ centers across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia. The company also delivers dialysis treatment through home-based setups, mobile vans (Dialysis on Wheels), temporary setups delivered to patient locations (Dialysis on Call), and a holiday dialysis program for traveling patients. It supplements these with digital services including a mobile app, AI-enabled clinical monitoring, and a technician training academy.

Is NephroPlus a public or private company?

NephroPlus is a public company. It is classified as public and is currently ipo.

When was NephroPlus founded?

NephroPlus was founded in 2009. It employs 1,001 to 5,000 people.

Where is NephroPlus based?

NephroPlus is headquartered in Hyderabad, India, in the Asia region.

How does NephroPlus make money?

Four revenue lines are on record. Dialysis Treatment Services are the primary driver. The others are public-Private Partnership (PPP) Programs, home and Specialty Dialysis Services and training and Academy Services.

Who are NephroPlus's main competitors?

Broad incumbents on record are DaVita, Fresenius Medical Care, B. Braun Avitum, Apollo Hospitals Enterprise, Fortis Healthcare and Max Healthcare Institute. Direct peers are Diaverum, U.S. Renal Care and Dialysis Clinic, Inc. (DCI). Asiri Hospitals Holdings is listed as a regional player.

Does NephroPlus have an API?

No public API is recorded for NephroPlus.

What industry is NephroPlus in?

NephroPlus's product category is Dialysis Care Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLAKAHAK, Home Dialysis Programs (Home HD/PD Training & Support). Its NAICS code is 621492 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business News TodayNomura maintains Buy on NephroPlus, cuts target price to Rs 770 as expansion weighs on margins- Moneycontrol.comNomura maintained a Buy on NephroPlus, cutting its target price to Rs 770 from Rs 780, citing expansion costs that weighed on margins. The company reported 23.5% revenue growth in Q2 FY27, with international markets contributing 47% to revenue. Nomura expects 15-20% revenue growth over the coming years.TradingViewNomura maintains Buy on NephroPlus, cuts target price to Rs 770 as expansion weighs on marginsNomura maintained a Buy rating on NephroPlus, cutting its target price to Rs 770 from Rs 780. The company reported 23.5% year-on-year revenue growth in Q2 FY27, but EBITDA margin fell to 22.1% due to expansion costs. Nomura expects 15-20% revenue growth over the next few years.TradingViewNEPHROPLUS: H1 revenue grew 23.6% as international expansion investments moderated marginsNephroplus reported H1 revenue of INR 585 crore, up 23.6% year-on-year, with adjusted EBITDA margin at 23%. The company entered Kazakhstan and maintains a medium-term revenue growth guidance of 15%–20%.TradingViewNEPHROPLUS: Q2 returned to consolidated profitability as revenue rose and international acquisitions expanded reachNephroplus reported Q2 consolidated revenue of INR 3,033.98 million and net profit of INR 335.31 million, returning to profitability. H1 revenue reached INR 5,851.52 million with net profit of INR 655.05 million. The company expanded its footprint through acquisitions in the Philippines and Kazakhstan, though purchase accounting remains provisional.EIN PresswireNephroplus Philippines brings kidney health awareness and prevention to indigenous community in Oriental MindoroNephroPlus Philippines held a kidney health medical mission in Oriental Mindoro for the Mangyan community, reaching 265 participants with screenings and counseling. The initiative, marking 50 clinics, included free blood pressure, blood sugar, and creatinine tests, plus nutrition guidance. The company aims to expand access to dialysis and kidney health awareness.Financial ExpressBeyond hospitals: 2 virtually debt-free healthcare stocks with 35%+ profit growthVijaya Diagnostic and Nephrocare Health Services are two debt-free healthcare stocks with strong growth. Vijaya's revenue rose 19.5% to ₹814.2 crore in FY26, while Nephrocare's grew 32.2% to ₹998.8 crore. Both are expanding into new geographies, with Vijaya planning 15 new hubs and Nephrocare targeting 40-50 clinics annually.Financial Express5 Inflation-Resistant Stocks to Watch Amid Rising Retail InflationIndia's September retail inflation hit 5.54%, the highest since October 2024, prompting the RBI to raise the repo rate to 5.50%. The article identifies five inflation-resistant stocks—Rainbow Children's Medicare, NephroPlus, Ipca Laboratories, Gillette India, and CRISIL—whose profits grew despite rising costs.Medical BuyerNephrocare investors to sell 9% stake for Rs 650 crore under block dealNephrocare Health Services Ltd is expected to see a block deal on Thursday, with investors offering up to 8.9% of equity for Rs 650 crore at Rs 705 per share. The offer includes a base of 5.5% (Rs 400 crore) and an upsize of 3.4% (Rs 250 crore). The company plans to continue expanding internationally, with international revenue contributing 42% of total revenue.CNBCTV18Nephrocare Health Services Block Deal: Investors likely to sell 9% stake at ₹705/share - CNBC TV18Nephrocare Health Services is likely to see a block deal on Thursday, with existing investors offering up to 8.9% of equity for ₹650 crore at ₹705 per share. The company expects 15-20% revenue growth over the next three to four years, supported by expansion and acquisitions.BusinessLineNephroPlus Launches NIDA – NephroPlus International Dialysis Academy – to Build a Global Pipeline of Dialysis-Trained NursesNephroPlus launched its NephroPlus International Dialysis Academy (NIDA) to train nursing graduates in India and the Philippines for dialysis care and international deployment. The first nodal centre opened in Hyderabad, with a second in Quezon City scheduled for November 2026. The programme includes classroom, simulation, and supervised clinical training, with successful candidates eligible for deployment within NephroPlus's international network.